Clinical Study

The Safety and Tolerability of 5-Aminolevulinic Acid Phosphate with Sodium Ferrous Citrate in Patients with Type 2 Diabetes Mellitus in Bahrain

Figure 3

Changes in mean HbA1c during dosing period ((a) ITT population, (b) PP population).
(a)
(b)